Gene · 135152
Papers1,850
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,850
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ferroptosis as a Novel Therapeutic Strategy to Overcome Multidrug Resistance in Colorectal Cancer. | Pharmaceuticals (Basel) | 2026 | 41754792 | PubTator, text mining | PubMed |
| Molecular Epidemiology of GSTM1 and GSTT1 Null Genotypes in High-Altitude Andean Populations of Peru. | Int J Mol Sci | 2026 | 41752144 | PubTator, text mining | PubMed |
| Inhibition of UDP-glucuronosyltransferases by fedratinib, implying a high risk of drug-drug interactions. | Chem Biol Interact | 2026 | 41747993 | PubTator, text mining | PubMed |
| Estimation of Prenatal Alcohol Exposure: Comparison of Retrospective Survey and Measurement of Fatty Acid Ethyl Esters, Ethyl Sulfate, and Ethyl Glucuronide Concentrations in Neonatal Meconium. | Toxics | 2026 | 41745829 | PubTator, text mining | PubMed |
| Targeting cancer hallmarks using resveratrol: isolation, formulation, and mechanisms of action. | Front Nutr | 2026 | 41737343 | PubTator, text mining | PubMed |
| Role of constitutive androstane receptor in developmental toxicology: linking chemical exposure, nutrition, and disease susceptibility. | Crit Rev Toxicol | 2026 | 41733502 | PubTator, text mining | PubMed |
| UGTformer: a pretrained graph transformer model for predicting UDP-glucuronosyltransferase-mediated drug metabolism. | J Cheminform | 2026 | 41634883 | PubTator, text mining | PubMed |
| Influence of 3-dimensional architecture and coculture on in vitro CYP enzyme metabolism and induction: Benchmarking human hepatic spheroids for studies in drug development. | Drug Metab Dispos | 2026 | 41604847 | PubTator, text mining | PubMed |
| The Role of Clinical Pharmacogenetics and Opioid Interactions in Pain Management: Current Evidence and Future Perspectives. | Pharmaceutics | 2026 | 41599166 | PubTator, text mining | PubMed |
| High Risk of Drug-Drug Interactions Caused by Pexidartinib via UDP-Glucuronosyltransferases Inhibition. | Chem Res Toxicol | 2026 | 41575265 | PubTator, text mining | PubMed |
| A neural glycan HNK-1 is transferred to recipient cells via small extracellular vesicles. | J Biol Chem | 2026 | 41534836 | PubTator, text mining | PubMed |
| Role of herbal extracts in modulating drug metabolism: implications for pharmacokinetics, enzyme regulation, and therapeutic outcome. | Drug Metab Rev | 2026 | 41392934 | PubTator, text mining | PubMed |
| Overexpression of UDP-glycosyltransferase UGT344B29 and UGT344B30 involved in lambda-cyhalothrin resistance in Aphis spiraecola. | Pestic Biochem Physiol | 2026 | 41350085 | PubTator, text mining | PubMed |
| Synergistic inhibitory effects of enzalutamide and its phase I metabolite on UDP-glucuronosyltransferase 1A1 (UGT1A1) and risk prediction of drug-drug interactions. | Chem Biol Interact | 2026 | 41241169 | PubTator, text mining | PubMed |
| Enhanced activity of glutathione S-transferases and other metabolic genes confer resistance to S-metolachlor in Abutilon theophrasti Medic. | Pest Manag Sci | 2026 | 41235587 | PubTator, text mining | PubMed |
| Report on the 2024 international phase II/N-acetyltransferase workshop. | Arch Toxicol | 2026 | 40885834 | PubTator, text mining | PubMed |
| Identification and Validation of Alkaliptosis Resistance-Associated Genes in Prostate Cancer Via Transcriptome Sequencing and Prediction of Biochemical Recurrence. | Mol Biotechnol | 2026 | 39760809 | PubTator, text mining | PubMed |
| Protein Abundance of Clinically Relevant Drug-Metabolizing Hydrolases in Human Liver and Intestine by Targeted versus Global Proteomics Approaches: A Comparative Study. | J Proteome Res | 2025 | 41082614 | PubTator, text mining | PubMed |
| Genomic Evolution and Patterns of Horizontal Gene Transfer in Coccomorpha Species. | Ecol Evol | 2025 | 41080486 | PubTator, text mining | PubMed |
| Multitissue analysis of absorption, distribution, metabolism, and excretion gene expression: Sex and age effects across human organ systems. | Drug Metab Dispos | 2025 | 41038000 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/135152/papers?page=2